Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00853593 · ClinicalTrials.gov registry record · NA
Model 4396 Left Ventricular (LV) Lead Study
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 197
- Enrollment target
NCT00853593 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 197 participants.
The verdict
NCT00853593, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 197 participants
- Enrollment target
Study Summary
This study is designed to show that a new lead, which paces the left bottom chamber (left ventricle) of the heart, is safe and effective. Using a lead on the left side of the heart has been shown to potentially improve heart failure symptoms. The shape and size of this new lead may make it a good choice for patients or physicians.
Interventions
- DEVICE Pacing Lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00853593
The ClinicalTrials.gov registry entry for NCT00853593 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pacing Lead is the first listed.
NCT00853593 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00853593 about?
NCT00853593 is a clinical study titled "Model 4396 Left Ventricular (LV) Lead Study". This study is designed to show that a new lead, which paces the left bottom chamber (left ventricle) of the heart, is safe and effective. Using a lead on the left side of the heart has been shown to potentially improve heart failure symptoms. The shape and size of this new lead may make it a good ch...
What is the current status of trial NCT00853593?
This trial is currently completed. It is a NA study. The enrollment target is 197 participants. The study started on 2009-03. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00853593?
The interventions under investigation include: Pacing Lead (DEVICE).
Who is sponsoring clinical trial NCT00853593?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.